JPRN-UMIN000036119
Completed
未知
A comparative study of renoprotective effect of tolvaptan as an alternative treatment for increasing loop diuretics in patients with chronic kidney disease complicated with chronic heart failure - A comparative study of renoprotective effect of tolvaptan as an alternative treatment for increasing loop diuretics in patients with chronic kidney disease complicated with chronic heart failure
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- chronic heart failure, chronic kidney disease
- Sponsor
- Kawashima hospital
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who cannot intake fluids or feel thirst Patients with anuria or urinary excretion disorder Patients with hypernatremia Patients with serious hepatic disorder Patients under the pacing therapy Patients with percutaneous coronary intervention or open heart surgery within the past 3 months Patients with poorly controlled diabetes mellitus Patients who take SGLT\-2 inhibitor Patients who are pregnant or possibly pregnant Patients without agreement on enrolment of this study Inappropriate patients judged by doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
This study will assess the effects of dapagliflozin (a drug that is used in patients with Type 2 Diabetes) on lowering the level of urine protein in patients with non-diabetic kidney disease.EUCTR2017-001090-16-NLniversity Medical Center Groningen53
Completed
Phase 3
A study to assess the renoprotective effects of the SGLT2 inhibitor Dapagliflozin in non-diabetic patients with proteinuria: a randomized double blind 6-week cross-over trialNL-OMON47662niversitair Medisch Centrum Groningen20
Not yet recruiting
Phase 4
In diabetes patients with kidney disease, which drug is better between pentoxifylline & dapagliflozin as an add on therapy to metformin, glimepiride & telmisartan in terms of kidney protection?Health Condition 1: E112- Type 2 diabetes mellitus with kidney complicationsCTRI/2023/10/059044Bhagat Phool Singh Govt. Medical College For Women
Not yet recruiting
Not Applicable
Study of renal function renal protective effect of cooling method in laparoscopic partial nephrectomyRenal cell cacinomaJPRN-UMIN000013867Kansai Medical University30
Completed
Not Applicable
The investigation of the renal protective effect of Carperitide(hANP:human atrial natriuretic peptide) during adult living donor renal transplantation, a single center experience.living donor renal transplantationJPRN-UMIN000014279Toho University School of Medicine, Department of Anesthesiology30